Ferredoxin 1 is a cuproptosis-key gene responsible for tumor immunity and drug sensitivity: A pan-cancer analysis
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Ferredoxin 1 is a cuproptosis-key gene responsible for tumor immunity and drug sensitivity: A pan-cancer analysis
Authors
Keywords
-
Journal
Frontiers in Pharmacology
Volume 13, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2022-09-21
DOI
10.3389/fphar.2022.938134
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Copper induces cell death by targeting lipoylated TCA cycle proteins
- (2022) Peter Tsvetkov et al. SCIENCE
- Alterations of DNA damage response pathway: Biomarker and therapeutic strategy for cancer immunotherapy
- (2021) Minlin Jiang et al. Acta Pharmaceutica Sinica B
- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Single‐cell RNA sequencing in cancer research
- (2021) Yijie Zhang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Pan-cancer association of HLA gene expression with cancer prognosis and immunotherapy efficacy
- (2021) Evelien Schaafsma et al. BRITISH JOURNAL OF CANCER
- Cancer statistics for the year 2020: An overview
- (2021) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- Overcoming anti-cancer drug resistance via restoration of tumor suppressor gene function
- (2021) Lingyue Gao et al. DRUG RESISTANCE UPDATES
- The role of FDX1 in granulosa cell of Polycystic ovary syndrome (PCOS)
- (2021) Zhi Wang et al. BMC Endocrine Disorders
- Impact of immune cells on the hallmarks of cancer: A literature review
- (2021) Alexandra C. Costa et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- FDX1 can Impact the Prognosis and Mediate the Metabolism of Lung Adenocarcinoma
- (2021) Zeyu Zhang et al. Frontiers in Pharmacology
- Relationships Between Immune Landscapes, Genetic Subtypes and Responses to Immunotherapy in Colorectal Cancer
- (2020) Emilie Picard et al. Frontiers in Immunology
- FDXR regulates TP73 tumor suppressor via IRP2 to modulate aging and tumor suppression
- (2020) Jin Zhang et al. JOURNAL OF PATHOLOGY
- Tumor microenvironment as a therapeutic target in cancer
- (2020) Yi Xiao et al. PHARMACOLOGY & THERAPEUTICS
- Delivery technologies for cancer immunotherapy
- (2019) Rachel S. Riley et al. NATURE REVIEWS DRUG DISCOVERY
- Mitochondrial metabolism promotes adaptation to proteotoxic stress
- (2019) Peter Tsvetkov et al. Nature Chemical Biology
- Immune cells within the tumor microenvironment: Biological functions and roles in cancer immunotherapy
- (2019) Xu Lei et al. CANCER LETTERS
- Targeting the ubiquitin-proteasome pathway to overcome anti-cancer drug resistance
- (2019) Silpa Narayanan et al. DRUG RESISTANCE UPDATES
- Ferredoxin reductase is critical for p53-dependent tumor suppression via iron regulatory protein 2
- (2017) Yanhong Zhang et al. GENES & DEVELOPMENT
- DNA Methylation in Cancer and Aging
- (2016) M. Klutstein et al. CANCER RESEARCH
- Post-transcriptional gene regulation by mRNA modifications
- (2016) Boxuan Simen Zhao et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Unmasking PD-1 Resistance by Next-Generation Sequencing
- (2016) Carlo B. Bifulco et al. NEW ENGLAND JOURNAL OF MEDICINE
- Genetic polymorphisms in TNFSF13 and FDX1 are associated with IgA nephropathy in the Han Chinese population
- (2015) Dan Niu et al. HUMAN IMMUNOLOGY
- Effects of silver nanoparticles on neonatal testis development in mice
- (2015) Sangiliyandi Gurunathan et al. International Journal of Nanomedicine
- Osthole, a coumadin analog from Cnidium monnieri (L.) Cusson, stimulates corticosterone secretion by increasing steroidogenic enzyme expression in mouse Y1 adrenocortical tumor cells
- (2015) Zhiqiang Pan et al. JOURNAL OF ETHNOPHARMACOLOGY
- Association betweenCCDC132,FDX1andTNFSF13gene polymorphisms and the risk of IgA nephropathy
- (2015) Dan Niu et al. NEPHROLOGY
- Transcriptional regulation of human ferredoxin 1 in ovarian granulosa cells
- (2013) Yoshitaka Imamichi et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- The Cancer Genome Atlas Pan-Cancer analysis project
- (2013) John N Weinstein et al. NATURE GENETICS
- Functional Characterization of Fdx1: Evidence for an Evolutionary Relationship between P450-Type and ISC-Type Ferredoxins
- (2011) Kerstin Maria Ewen et al. JOURNAL OF MOLECULAR BIOLOGY
- Anti-cancer drug resistance: Understanding the mechanisms through the use of integrative genomics and functional RNA interference
- (2010) Daniel S.-W. Tan et al. EUROPEAN JOURNAL OF CANCER
- Microarray analysis identifies distinct gene expression profiles associated with histological subtype in human osteosarcoma
- (2010) Bernd Kubista et al. INTERNATIONAL ORTHOPAEDICS
- Humans possess two mitochondrial ferredoxins, Fdx1 and Fdx2, with distinct roles in steroidogenesis, heme, and Fe/S cluster biosynthesis
- (2010) A. D. Sheftel et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Regulation of XIAP Translation and Induction by MDM2 following Irradiation
- (2009) Lubing Gu et al. CANCER CELL
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search